UNITED THERAPEUTICS Corp
For the period ended Mar 31, 2024. Filed May 1, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 1, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Income
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| (Unaudited) | ||
| Net income | $306.6 | $240.9 |
| Other comprehensive (loss) income: | ||
| Foreign currency translation loss included in net income | 2.4 | — |
| Defined benefit pension plan: | ||
| Actuarial loss arising during period, net of tax | (0.5) | (0.9) |
| Actuarial gain and prior service cost included in net periodic pension cost, net of tax | (1.2) | (2.3) |
| Total defined benefit pension plan, net of tax | (1.7) | (3.2) |
| Available-for-sale debt securities: | ||
| Unrealized (loss) gain arising during period, net of tax | (4.6) | 19.9 |
| Realized loss included in net income, net of tax | 1.1 | — |
| Total (loss) gain on available-for-sale debt securities, net of tax | (3.5) | 19.9 |
| Other comprehensive (loss) income, net of tax | (2.8) | 16.7 |
| Comprehensive income | $303.8 | $257.6 |
During the three months ended March 31, 2024 and 2023, the tax (benefit) expense in other comprehensive income was $(0.1) million and $(0.5) million, respectively, for the defined benefit pension plan and $(1.2) million and $6.3 million, respectively, for the available-for-sale debt securities.
| Quarterly Report | 5 |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.